166 related articles for article (PubMed ID: 24103048)
1. Podoplanin is expressed at the invasive front of esophageal squamous cell carcinomas and is involved in collective cell invasion.
Nakashima Y; Yoshinaga K; Kitao H; Ando K; Kimura Y; Saeki H; Oki E; Morita M; Kakeji Y; Hirahashi M; Oda Y; Maehara Y
Cancer Sci; 2013 Dec; 104(12):1718-25. PubMed ID: 24103048
[TBL] [Abstract][Full Text] [Related]
2. Podoplanin-mediated TGF-β-induced epithelial-mesenchymal transition and its correlation with bHLH transcription factor DEC in TE-11 cells.
Wu Y; Liu Q; Yan X; Kato Y; Tanaka M; Inokuchi S; Yoshizawa T; Morohashi S; Kijima H
Int J Oncol; 2016 Jun; 48(6):2310-20. PubMed ID: 27035755
[TBL] [Abstract][Full Text] [Related]
3. PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.
Cui XB; Zhang SM; Xu YX; Dang HW; Liu CX; Wang LH; Yang L; Hu JM; Liang WH; Jiang JF; Li N; Li Y; Chen YZ; Li F
J Transl Med; 2016 May; 14(1):137. PubMed ID: 27188458
[TBL] [Abstract][Full Text] [Related]
4. Expression of podoplanin and vimentin is correlated with prognosis in esophageal squamous cell carcinoma.
Tanaka M; Kijima H; Shimada H; Makuuchi H; Ozawa S; Inokuchi S
Mol Med Rep; 2015 Sep; 12(3):4029-4036. PubMed ID: 26095281
[TBL] [Abstract][Full Text] [Related]
5. MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1.
Yokobori T; Suzuki S; Tanaka N; Inose T; Sohda M; Sano A; Sakai M; Nakajima M; Miyazaki T; Kato H; Kuwano H
Cancer Sci; 2013 Jan; 104(1):48-54. PubMed ID: 23013135
[TBL] [Abstract][Full Text] [Related]
6. The glioma-associated oncogene homolog 1 promotes epithelial--mesenchymal transition in human esophageal squamous cell cancer by inhibiting E-cadherin via Snail.
Min S; Xiaoyan X; Fanghui P; Yamei W; Xiaoli Y; Feng W
Cancer Gene Ther; 2013 Jul; 20(7):379-85. PubMed ID: 23788111
[TBL] [Abstract][Full Text] [Related]
7. Myosin 5a regulates tumor migration and epithelial-mesenchymal transition in esophageal squamous cell carcinoma: utility as a prognostic factor.
Sato N; Fujishima F; Nakamura Y; Aoyama Y; Onodera Y; Ozawa Y; Ito K; Ishida H; Kamei T; Watanabe M; Sasano H
Hum Pathol; 2018 Oct; 80():113-122. PubMed ID: 29898384
[TBL] [Abstract][Full Text] [Related]
8. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y
Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728
[TBL] [Abstract][Full Text] [Related]
9. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
10. Snail-associated epithelial-mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression.
Usami Y; Satake S; Nakayama F; Matsumoto M; Ohnuma K; Komori T; Semba S; Ito A; Yokozaki H
J Pathol; 2008 Jul; 215(3):330-9. PubMed ID: 18491351
[TBL] [Abstract][Full Text] [Related]
11. Loss of miR-200b promotes invasion via activating the Kindlin-2/integrin β1/AKT pathway in esophageal squamous cell carcinoma: An E-cadherin-independent mechanism.
Zhang HF; Alshareef A; Wu C; Li S; Jiao JW; Cao HH; Lai R; Xu LY; Li EM
Oncotarget; 2015 Oct; 6(30):28949-60. PubMed ID: 26334393
[TBL] [Abstract][Full Text] [Related]
12. Tumorigenic role of podoplanin in esophageal squamous-cell carcinoma.
Rahadiani N; Ikeda J; Makino T; Tian T; Qiu Y; Mamat S; Wang Y; Doki Y; Aozasa K; Morii E
Ann Surg Oncol; 2010 May; 17(5):1311-23. PubMed ID: 20066519
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-145 Inhibits Cell Migration and Invasion and Regulates Epithelial-Mesenchymal Transition (EMT) by Targeting Connective Tissue Growth Factor (CTGF) in Esophageal Squamous Cell Carcinoma.
Han Q; Zhang HY; Zhong BL; Wang XJ; Zhang B; Chen H
Med Sci Monit; 2016 Oct; 22():3925-3934. PubMed ID: 27771733
[TBL] [Abstract][Full Text] [Related]
14. MiR-424-5p participates in esophageal squamous cell carcinoma invasion and metastasis via SMAD7 pathway mediated EMT.
Wang F; Wang J; Yang X; Chen D; Wang L
Diagn Pathol; 2016 Sep; 11(1):88. PubMed ID: 27628042
[TBL] [Abstract][Full Text] [Related]
15. Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition.
Lee KW; Kim JH; Han S; Sung CO; Do IG; Ko YH; Um SH; Kim SH
Ann Surg Oncol; 2012 Jan; 19(1):326-35. PubMed ID: 21732143
[TBL] [Abstract][Full Text] [Related]
16. Concordant podoplanin expression in cancer-associated fibroblasts and tumor cells is an adverse prognostic factor in esophageal squamous cell carcinoma.
Chuang WY; Yeh CJ; Chao YK; Liu YH; Chang YS; Tseng CK; Chang HK; Wan YL; Hsueh C
Int J Clin Exp Pathol; 2014; 7(8):4847-56. PubMed ID: 25197355
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathology significance of podoplanin immunoreactivity in esophageal squamous cell carcinoma.
Ma W; Wang K; Yang S; Wang J; Tan B; Bai B; Wang N; Jia Y; Jia M; Cheng Y
Int J Clin Exp Pathol; 2014; 7(5):2361-71. PubMed ID: 24966946
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of SPOCK1 induces epithelial-mesenchymal transition and promotes migration and invasion in esophageal squamous cell carcinoma.
Song X; Han P; Liu J; Wang Y; Li D; He J; Gong J; Li M; Tu W; Yan W; Liu M; Huang H; Tian D; Liao J
J Mol Histol; 2015 Oct; 46(4-5):347-56. PubMed ID: 26077618
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma.
Li P; Liu X; Dong ZM; Ling ZQ
Oncotarget; 2015 Nov; 6(35):38151-65. PubMed ID: 26510908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]